Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

MDT Medtronic Earnings and EPS analysis

EPS in 2025 (TTM): $3.31

Last Report Period Date: Jan 24, 2025

As of June 2025, MDT's current EPS stands at $3.31, according to the latest financial reports. For the year 2024, the company recorded an earnings per share (EPS) of $2.77, which marks a drop compared to its EPS of $2.83 in 2023. MDT reported an EPS of $1.01 for the quarterly report ending on Jan 24, 2025.

MDT earnings history

Historical annual and quarterly earnings per share (EPS) data for Medtronic
EPS (TTM)
$3.31
EPS Growth YoY (Quarterly)
2%
EPS (Quarterly)
$1.01
EPS Growth (Quarterly)
2%

For 2024, Medtronic's EPS was $2.77, a drop of 2.1% from $2.83 in 2023. For the fiscal quarter that ended on Jan 24, 2025, the per-share earnings was $1.01, showing a 2% increase from the same quarter last year. For the twelve months ending January 2025, the EPS is $3.31. For the year 2023, the yearly earnings per share was $2.83, marking a decrease of 24.5% from 2022.

MDT EPS growth

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
2%
EPS growth YoY
-2.1%
EPS growth 3Y avg
1.1%
EPS growth 5Y avg
-4.2%

Medtronic has registered an increase in EPS of 2% during the last 12 months (YoY, quarterly). In the last three years, MDT recorded an average annual EPS growth rate of 1.1%. Medtronic had an average annual EPS growth rate of -4.2% during the last 5 years. Across the last decade, MDT had an average annual EPS growth of -1%.

MDT Earnings Waterfall

Breakdown of revenue, profit and net income for Medtronic

MDT Earnings vs Peers

What are the earnings of MDT compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
EW Edwards Lifesciences Corp 11.07 202.2% 42.5% 33%
CNMD CONMED Corp 14.73 104.3% 26.1% 33.5%
JNJ Johnson & Johnson 16.91 -57.9% -9.7% 0.4%
ABT Abbott Laboratories 17.22 133.8% 24.5% 29.9%
MDT Medtronic plc 25.86 -2.1% 1.1% -4.2%
SYK Stryker Corp 51.01 -5.8% 14.1% 7.1%
BSX Boston Scientific Corp 74.22 16.7% 22.2% -17.9%
BAX Baxter International Inc N/A -124.2% N/A N/A
OMI Owens & Minor Inc N/A -775.9% N/A N/A
IART Integra Lifesciences Holdings Corp N/A -110.6% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.